InfuSystem Holdings, Inc. (AMEX: INFU) Stock Competitors & Peer Comparison
See INFU's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for INFU and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INFU | $12.30 | +0.57% | 245.8M | 29.71 | $0.41 | N/A |
| ISRG | $391.80 | +0.16% | 140.5B | 41.34 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.00% |
| BDX | $189.35 | +4.74% | 51.7B | 14.43 | $13.00 | +2.00% |
| MDLN | $33.07 | -3.08% | 28.7B | 24.85 | $1.36 | N/A |
| WST | $357.78 | +3.23% | 24.8B | 44.29 | $7.97 | +0.25% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $89.34 | +2.16% | 15.2B | 12.37 | $7.10 | N/A |
| COO | $76.91 | +1.52% | 15B | 16.83 | $4.56 | N/A |
| BAX | $26.46 | +2.00% | 13.8B | 12.82 | $2.08 | +0.75% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
INFU vs ISRG Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, ISRG has a market cap of 140.5B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while ISRG trades at $391.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas ISRG's P/E ratio is 41.34. In terms of profitability, INFU's ROE is +0.15%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, INFU is less volatile compared to ISRG. This indicates lower risk in terms of short-term price fluctuations for INFU.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
INFU vs BDXA Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas BDXA's P/E ratio is 45.70. In terms of profitability, INFU's ROE is +0.15%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, INFU is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for INFU.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
INFU vs BDX Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, BDX has a market cap of 51.7B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while BDX trades at $189.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas BDX's P/E ratio is 14.43. In terms of profitability, INFU's ROE is +0.15%, compared to BDX's ROE of +0.04%. Regarding short-term risk, INFU is less volatile compared to BDX. This indicates lower risk in terms of short-term price fluctuations for INFU.Check BDX's competition here
Medline Inc. (NASDAQ: MDLN)
INFU vs MDLN Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, MDLN has a market cap of 28.7B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while MDLN trades at $33.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas MDLN's P/E ratio is 24.85. In terms of profitability, INFU's ROE is +0.15%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, INFU is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for INFU.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
INFU vs WST Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, WST has a market cap of 24.8B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while WST trades at $357.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas WST's P/E ratio is 44.29. In terms of profitability, INFU's ROE is +0.15%, compared to WST's ROE of +0.19%. Regarding short-term risk, INFU is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for INFU.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
INFU vs HOLX Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas HOLX's P/E ratio is 31.54. In terms of profitability, INFU's ROE is +0.15%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, INFU is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for INFU.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
INFU vs SOLV Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, SOLV has a market cap of 15.2B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while SOLV trades at $89.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas SOLV's P/E ratio is 12.37. In terms of profitability, INFU's ROE is +0.15%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, INFU is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for INFU.Check SOLV's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
INFU vs COO Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, COO has a market cap of 15B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while COO trades at $76.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas COO's P/E ratio is 16.83. In terms of profitability, INFU's ROE is +0.15%, compared to COO's ROE of +0.03%. Regarding short-term risk, INFU is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for INFU.Check COO's competition here
Baxter International Inc. (NYSE: BAX)
INFU vs BAX Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, BAX has a market cap of 13.8B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while BAX trades at $26.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas BAX's P/E ratio is 12.82. In terms of profitability, INFU's ROE is +0.15%, compared to BAX's ROE of -0.17%. Regarding short-term risk, INFU is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for INFU.Check BAX's competition here
Becton, Dickinson and Company (NYSE: BDXB)
INFU vs BDXB Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas BDXB's P/E ratio is 7.60. In terms of profitability, INFU's ROE is +0.15%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, INFU is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for INFU.Check BDXB's competition here
Repligen Corporation (NASDAQ: RGEN)
INFU vs RGEN Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, RGEN has a market cap of 10B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while RGEN trades at $184.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas RGEN's P/E ratio is 97.98. In terms of profitability, INFU's ROE is +0.15%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, INFU is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for INFU.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
INFU vs AVTR Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, AVTR has a market cap of 9.5B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while AVTR trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas AVTR's P/E ratio is 16.44. In terms of profitability, INFU's ROE is +0.15%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, INFU is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for INFU.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
INFU vs ATR Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, ATR has a market cap of 8.5B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while ATR trades at $133.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas ATR's P/E ratio is 23.24. In terms of profitability, INFU's ROE is +0.15%, compared to ATR's ROE of +0.14%. Regarding short-term risk, INFU is less volatile compared to ATR. This indicates lower risk in terms of short-term price fluctuations for INFU.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
INFU vs BLCO Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, BLCO has a market cap of 6.2B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while BLCO trades at $17.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas BLCO's P/E ratio is 26.85. In terms of profitability, INFU's ROE is +0.15%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, INFU is less volatile compared to BLCO. This indicates lower risk in terms of short-term price fluctuations for INFU.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
INFU vs TFX Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, TFX has a market cap of 6B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while TFX trades at $136.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas TFX's P/E ratio is 15.54. In terms of profitability, INFU's ROE is +0.15%, compared to TFX's ROE of -0.32%. Regarding short-term risk, INFU is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for INFU.Check TFX's competition here
Stevanato Group S.p.A. (NYSE: STVN)
INFU vs STVN Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, STVN has a market cap of 5.9B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while STVN trades at $22.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas STVN's P/E ratio is 32.92. In terms of profitability, INFU's ROE is +0.15%, compared to STVN's ROE of +0.09%. Regarding short-term risk, INFU is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for INFU.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
INFU vs MMSI Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, MMSI has a market cap of 5.5B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while MMSI trades at $90.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas MMSI's P/E ratio is 23.52. In terms of profitability, INFU's ROE is +0.15%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, INFU is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for INFU.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
INFU vs ICUI Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, ICUI has a market cap of 4.7B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while ICUI trades at $187.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas ICUI's P/E ratio is 23.38. In terms of profitability, INFU's ROE is +0.15%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, INFU is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for INFU.Check ICUI's competition here
Envista Holdings Corp (NYSE: NVST)
INFU vs NVST Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, NVST has a market cap of 4.5B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while NVST trades at $27.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas NVST's P/E ratio is 18.93. In terms of profitability, INFU's ROE is +0.15%, compared to NVST's ROE of +0.04%. Regarding short-term risk, INFU is less volatile compared to NVST. This indicates lower risk in terms of short-term price fluctuations for INFU.Check NVST's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
INFU vs PLSE Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, PLSE has a market cap of 3.3B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while PLSE trades at $48.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas PLSE's P/E ratio is -39.85. In terms of profitability, INFU's ROE is +0.15%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, INFU is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for INFU.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
INFU vs ATRC Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, ATRC has a market cap of 2.4B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while ATRC trades at $47.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas ATRC's P/E ratio is 1478.57. In terms of profitability, INFU's ROE is +0.15%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, INFU is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for INFU.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
INFU vs XRAY Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, XRAY has a market cap of 2.2B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while XRAY trades at $10.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas XRAY's P/E ratio is 7.71. In terms of profitability, INFU's ROE is +0.15%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, INFU is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for INFU.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
INFU vs LMAT Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while LMAT trades at $82.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas LMAT's P/E ratio is 30.83. In terms of profitability, INFU's ROE is +0.15%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, INFU is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for INFU.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
INFU vs BLFS Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, BLFS has a market cap of 1.8B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while BLFS trades at $37.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas BLFS's P/E ratio is -172.56. In terms of profitability, INFU's ROE is +0.15%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, INFU is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for INFU.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
INFU vs AZTA Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, AZTA has a market cap of 1.6B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while AZTA trades at $36.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas AZTA's P/E ratio is 84.81. In terms of profitability, INFU's ROE is +0.15%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, INFU is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for INFU.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
INFU vs KMTS Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, KMTS has a market cap of 1.6B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while KMTS trades at $27.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas KMTS's P/E ratio is -11.83. In terms of profitability, INFU's ROE is +0.15%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, INFU is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for INFU.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
INFU vs STAA Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while STAA trades at $23.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas STAA's P/E ratio is 43.26. In terms of profitability, INFU's ROE is +0.15%, compared to STAA's ROE of +0.01%. Regarding short-term risk, INFU is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for INFU.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
INFU vs QDEL Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, QDEL has a market cap of 941M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while QDEL trades at $14.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas QDEL's P/E ratio is 10.30. In terms of profitability, INFU's ROE is +0.15%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, INFU is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for INFU.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
INFU vs ATRI Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas ATRI's P/E ratio is 64.50. In terms of profitability, INFU's ROE is +0.15%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, INFU is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for INFU.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
INFU vs ANGO Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, ANGO has a market cap of 664.2M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while ANGO trades at $15.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas ANGO's P/E ratio is -41.21. In terms of profitability, INFU's ROE is +0.15%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, INFU is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for INFU.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
INFU vs NNNN Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, NNNN has a market cap of 366.5M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while NNNN trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas NNNN's P/E ratio is 120.66. In terms of profitability, INFU's ROE is +0.15%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, INFU is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for INFU.Check NNNN's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
INFU vs SMTI Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, SMTI has a market cap of 315.1M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while SMTI trades at $34.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas SMTI's P/E ratio is -571.33. In terms of profitability, INFU's ROE is +0.15%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, INFU is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for INFU.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
INFU vs OSUR Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, OSUR has a market cap of 258.2M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while OSUR trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas OSUR's P/E ratio is -6.82. In terms of profitability, INFU's ROE is +0.15%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, INFU is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for INFU.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
INFU vs UTMD Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, UTMD has a market cap of 229.6M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while UTMD trades at $72.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas UTMD's P/E ratio is 21.34. In terms of profitability, INFU's ROE is +0.15%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, INFU is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for INFU.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
INFU vs PDEX Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, PDEX has a market cap of 213.7M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while PDEX trades at $66.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas PDEX's P/E ratio is 23.57. In terms of profitability, INFU's ROE is +0.15%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, INFU is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for INFU.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
INFU vs KRMD Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, KRMD has a market cap of 152.5M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while KRMD trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas KRMD's P/E ratio is -83.00. In terms of profitability, INFU's ROE is +0.15%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, INFU is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for INFU.Check KRMD's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
INFU vs MBOT Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, MBOT has a market cap of 70.6M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while MBOT trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas MBOT's P/E ratio is -5.96. In terms of profitability, INFU's ROE is +0.15%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, INFU is less volatile compared to MBOT. This indicates lower risk in terms of short-term price fluctuations for INFU.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
INFU vs AKYA Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas AKYA's P/E ratio is -1.34. In terms of profitability, INFU's ROE is +0.15%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, INFU is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for INFU.Check AKYA's competition here
Daxor Corporation (NASDAQ: DXR)
INFU vs DXR Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, DXR has a market cap of 60.1M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while DXR trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas DXR's P/E ratio is 5.67. In terms of profitability, INFU's ROE is +0.15%, compared to DXR's ROE of +0.22%. Regarding short-term risk, INFU is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for INFU.Check DXR's competition here
SkyAI, Inc. (NASDAQ: STSS)
INFU vs STSS Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas STSS's P/E ratio is -0.02. In terms of profitability, INFU's ROE is +0.15%, compared to STSS's ROE of -1.54%. Regarding short-term risk, INFU is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for INFU.Check STSS's competition here
Nephros, Inc. (NASDAQ: NEPH)
INFU vs NEPH Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, NEPH has a market cap of 51.7M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while NEPH trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas NEPH's P/E ratio is 79.33. In terms of profitability, INFU's ROE is +0.15%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, INFU is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for INFU.Check NEPH's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
INFU vs OMIC Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas OMIC's P/E ratio is -0.58. In terms of profitability, INFU's ROE is +0.15%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, INFU is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for INFU.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
INFU vs IGAP Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas IGAP's P/E ratio is -10.52. In terms of profitability, INFU's ROE is +0.15%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, INFU is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for INFU.Check IGAP's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
INFU vs POCI Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, POCI has a market cap of 48.6M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while POCI trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas POCI's P/E ratio is -6.17. In terms of profitability, INFU's ROE is +0.15%, compared to POCI's ROE of -0.37%. Regarding short-term risk, INFU is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for INFU.Check POCI's competition here
Milestone Scientific Inc. (AMEX: MLSS)
INFU vs MLSS Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, MLSS has a market cap of 42.4M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while MLSS trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas MLSS's P/E ratio is -7.99. In terms of profitability, INFU's ROE is +0.15%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, INFU is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for INFU.Check MLSS's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
INFU vs HBIO Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, HBIO has a market cap of 31.9M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while HBIO trades at $7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas HBIO's P/E ratio is -19.67. In terms of profitability, INFU's ROE is +0.15%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, INFU is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for INFU.Check HBIO's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
INFU vs SDC Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas SDC's P/E ratio is -0.03. In terms of profitability, INFU's ROE is +0.15%, compared to SDC's ROE of -1.96%. Regarding short-term risk, INFU is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for INFU.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
INFU vs IVC Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas IVC's P/E ratio is -0.79. In terms of profitability, INFU's ROE is +0.15%, compared to IVC's ROE of -0.46%. Regarding short-term risk, INFU is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for INFU.Check IVC's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
INFU vs ZJYL Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, ZJYL has a market cap of 24.1M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while ZJYL trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas ZJYL's P/E ratio is 19.25. In terms of profitability, INFU's ROE is +0.15%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, INFU is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for INFU.Check ZJYL's competition here
Retractable Technologies, Inc. (AMEX: RVP)
INFU vs RVP Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, RVP has a market cap of 21.7M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while RVP trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas RVP's P/E ratio is -2.20. In terms of profitability, INFU's ROE is +0.15%, compared to RVP's ROE of -0.05%. Regarding short-term risk, INFU is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for INFU.Check RVP's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
INFU vs RGNT Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, RGNT has a market cap of 15.6M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while RGNT trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas RGNT's P/E ratio is -0.09. In terms of profitability, INFU's ROE is +0.15%, compared to RGNT's ROE of N/A. Regarding short-term risk, INFU is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for INFU.Check RGNT's competition here
Femasys Inc. (NASDAQ: FEMY)
INFU vs FEMY Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, FEMY has a market cap of 7.9M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while FEMY trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas FEMY's P/E ratio is -7.21. In terms of profitability, INFU's ROE is +0.15%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, INFU is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for INFU.Check FEMY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
INFU vs NSTG Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas NSTG's P/E ratio is -0.03. In terms of profitability, INFU's ROE is +0.15%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, INFU is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for INFU.Check NSTG's competition here
Lucyd, Inc (NASDAQ: LUCY)
INFU vs LUCY Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, LUCY has a market cap of 4.4M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while LUCY trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas LUCY's P/E ratio is -0.41. In terms of profitability, INFU's ROE is +0.15%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, INFU is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for INFU.Check LUCY's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
INFU vs POAI Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas POAI's P/E ratio is -0.03. In terms of profitability, INFU's ROE is +0.15%, compared to POAI's ROE of -21.19%. Regarding short-term risk, INFU is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for INFU.Check POAI's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
INFU vs NXGL Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, NXGL has a market cap of 3.3M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while NXGL trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas NXGL's P/E ratio is -0.55. In terms of profitability, INFU's ROE is +0.15%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, INFU is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for INFU.Check NXGL's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
INFU vs GCTK Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, GCTK has a market cap of 2.7M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while GCTK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas GCTK's P/E ratio is -0.02. In terms of profitability, INFU's ROE is +0.15%, compared to GCTK's ROE of -21.36%. Regarding short-term risk, INFU is less volatile compared to GCTK. This indicates lower risk in terms of short-term price fluctuations for INFU.Check GCTK's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
INFU vs MHUA Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas MHUA's P/E ratio is 0.25. In terms of profitability, INFU's ROE is +0.15%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, INFU is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for INFU.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
INFU vs GMVD Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas GMVD's P/E ratio is -0.01. In terms of profitability, INFU's ROE is +0.15%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, INFU is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for INFU.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
INFU vs GMVDW Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas GMVDW's P/E ratio is N/A. In terms of profitability, INFU's ROE is +0.15%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, INFU is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for INFU.Check GMVDW's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
INFU vs NXGLW Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, NXGLW has a market cap of 1.5M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas NXGLW's P/E ratio is -0.05. In terms of profitability, INFU's ROE is +0.15%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, INFU is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for INFU.Check NXGLW's competition here
Avinger, Inc. (NASDAQ: AVGR)
INFU vs AVGR Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas AVGR's P/E ratio is -0.05. In terms of profitability, INFU's ROE is +0.15%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, INFU is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for INFU.Check AVGR's competition here
Lucyd, Inc (NASDAQ: LUCYW)
INFU vs LUCYW Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas LUCYW's P/E ratio is N/A. In terms of profitability, INFU's ROE is +0.15%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, INFU is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for INFU.Check LUCYW's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
INFU vs ATRS Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas ATRS's P/E ratio is 14.95. In terms of profitability, INFU's ROE is +0.15%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, INFU is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for INFU.Check ATRS's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
INFU vs HRC Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, HRC has a market cap of 0. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas HRC's P/E ratio is 41.92. In terms of profitability, INFU's ROE is +0.15%, compared to HRC's ROE of +0.14%. Regarding short-term risk, INFU is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for INFU.Check HRC's competition here
Apria, Inc. (NASDAQ: APR)
INFU vs APR Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, APR has a market cap of 0. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas APR's P/E ratio is 22.59. In terms of profitability, INFU's ROE is +0.15%, compared to APR's ROE of +9.81%. Regarding short-term risk, INFU is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for INFU.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
INFU vs IIN Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, IIN has a market cap of 0. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas IIN's P/E ratio is 226.45. In terms of profitability, INFU's ROE is +0.15%, compared to IIN's ROE of -0.00%. Regarding short-term risk, INFU is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for INFU.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
INFU vs ALOG Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, ALOG has a market cap of 0. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas ALOG's P/E ratio is 40.93. In terms of profitability, INFU's ROE is +0.15%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, INFU is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for INFU.Check ALOG's competition here
Invuity, Inc. (NASDAQ: IVTY)
INFU vs IVTY Comparison August 2026
InfuSystem Holdings, Inc. (AMEX: INFU) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFU stands at 245.8M. In comparison, IVTY has a market cap of 0. Regarding current trading prices, INFU is priced at $12.30 on the AMEX, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFU currently has a P/E ratio of 29.71, whereas IVTY's P/E ratio is -3.80. In terms of profitability, INFU's ROE is +0.15%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, INFU is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for INFU.Check IVTY's competition here